IRD · Insider Trading
Opus Genetics, Inc. Common Stock
Every open-market purchase and sale reported by IRD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Foundation Fighting Blindness, Inc. | Director | Sell | −1,112,000 | −$5.51M |
| 2026-09-11 | George Magrath | Chief Executive Officer | MIXED | +316,616 | +$1 |
| 2026-09-08 | Cam Gallagher | Director | M | +784,314 | +$901.96K |
| 2026-09-08 | Robert E. Gagnon | Chief Financial Officer | Sell | −28,000 | −$127.21K |
| 2026-07-27 | Robert E. Gagnon | Chief Financial Officer | Sell | −7,783 | −$22.94K |
| 2026-07-27 | Benjamin R Yerxa | President | Sell | −7,429 | −$22.06K |
| 2026-07-27 | Joseph K Schachle | Chief Operating Officer | Sell | −4,644 | −$13.65K |
| 2026-07-27 | George Magrath | Chief Executive Officer | Sell | −9,475 | −$27.93K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Foundation Fighting Blindness, Inc. | Director | 3,236,171 | $10.74M |
| Cam Gallagher | Director | 2,883,111 | $9.57M |
| George Magrath | Chief Executive Officer | 2,124,026 | $7.05M |
| Benjamin R Yerxa | President | 704,106 | $2.34M |
| Robert E. Gagnon | Chief Financial Officer | 556,375 | $1.85M |
| Joseph K Schachle | Chief Operating Officer | 291,440 | $967.58K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IRD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.